Inhibition of MHC II gene transcription by nitric oxide and antioxidants. - Wikidata - wikimedia - TriplyDB

Inhibition of MHC II gene transcription by nitric oxide and antioxidants.

Inhibition of MHC II gene transcription by nitric oxide and antioxidants.

http://www.wikidata.org/entity/Q35699343

about

Mesenchymal Stem Cells and Myeloid Derived Suppressor Cells: Common Traits in Immune Regulation mTOR inhibitors effects on regulatory T cells and on dendritic cells Transplantation Tolerance Induction: Cell Therapies and Their Mechanisms Novel immunotherapeutic approaches for the treatment of acute leukemia (myeloid and lymphoblastic)Paving the Road to Tumor Development and Spreading: Myeloid-Derived Suppressor Cells are Ruling the Fate Exploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer Immunotherapy From tumor immunosuppression to eradication: targeting homing and activity of immune effector cells to tumors COX-2 and PGE2-dependent immunomodulation in breast cancer Multiple sclerosis: molecular mechanisms and therapeutic opportunities Myeloid-derived suppressor cells as regulators of the immune system The role of myeloid-derived suppressor cells in immune ontogeny Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species.Ageing and myeloid-derived suppressor cells: possible involvement in immunosenescence and age-related disease.Dopamine inhibits the function of Gr-1+CD115+ myeloid-derived suppressor cells through D1-like receptors and enhances anti-tumor immunity.Tumor microenvironment: a new treatment target for cancer Myeloid-derived suppressor cells participate in preventing graft rejection.Characterization of Liver Monocytic Myeloid-Derived Suppressor Cells and Their Role in a Murine Model of Non-Alcoholic Fatty Liver Disease.Tolerance-inducing strategies in islet transplantation Suppression of dendritic cell maturation and T cell proliferation by synovial fluid myeloid cells from mice with autoimmune arthritis.CD38-Expressing Myeloid-Derived Suppressor Cells Promote Tumor Growth in a Murine Model of Esophageal Cancer.Accumulation of myeloid-derived suppressor cells in the lungs during Pneumocystis pneumonia The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells.Myeloid derived suppressor cells: Targets for therapy.Dysregulated TLR3-dependent signaling and innate immune activation in superoxide-deficient macrophages from nonobese diabetic mice Myeloid-derived suppressor cells and myeloid regulatory cells in cancer and autoimmune disorders NF-Y and the transcriptional activation of CCAAT promoters.Regulation of suppressive function of myeloid-derived suppressor cells by CD4+ T cells Myeloid-derived suppressor cells: mechanisms of action and recent advances in their role in transplant tolerance.Reactive oxygen species in the immune system.T-cell tolerance in cancer.Myeloid-derived suppressor cells in glioma.Cellular and molecular mechanisms in cancer immune escape: a comprehensive review.Insights into Myeloid-Derived Suppressor Cells in Inflammatory Diseases.Myeloid-derived suppressor cells in B cell malignancies.Myeloid-derived suppressor cells as effectors of immune suppression in cancer.Myeloid-derived suppressor cells in murine AIDS inhibit B-cell responses in part via soluble mediators including reactive oxygen and nitrogen species, and TGF-β.Metabolism in cancer metastasis: bioenergetics, biosynthesis, and beyond.Reactive oxygen species are essential mediators in antigen presentation by Kupffer cells.Translational Potential of Therapeutics Targeting Regulatory Myeloid Cells in Tuberculosis Myeloid-derived suppressor cells in non-neoplastic inflamed organs

P2860

Q26741252-6F4C14A6-08A5-446D-80BD-88364B443BF0 Q26744447-10D5BF5A-2EB0-46EF-9A5D-782B9A4C3D0A Q26751022-D87B97AC-7A5E-43F1-AF17-0FA8C358E851 Q26770391-991C41E2-C5E2-487B-83D4-97F5F326C8C8 Q26777205-F734B83A-4A60-4BE7-B634-72CCB41D83F1 Q26779184-7928173D-BA8F-4B84-8BF3-5D7B2F18D310 Q26865532-D3EC4E47-49A3-4F1C-9FE4-368AECF56F65 Q27003937-7069C620-DAF0-4F18-8A26-6287294E4DFC Q27023735-53A545F4-5F0D-4F61-BAB0-ECFFAC4259E0 Q28131637-CEA7A7F7-39FD-43E5-A739-3845FEE23912 Q28654584-C4943CD6-9B06-4267-8FE7-9E657FDA42D5 Q30422587-20A8DB86-9367-4184-ABF0-2FFAB9C81144 Q34517267-BE200182-EF81-447C-8012-5EA0D45595CB Q35227738-0B1E5878-F591-42B3-8807-FE1CD7467552 Q35361431-032380E7-73F9-44F7-9B91-02AD20301FF3 Q35852813-D5D087C7-7280-4250-89CE-96D92F92ACAF Q35931096-DFC8F808-8588-46A9-9A7A-AB5A04EE15D5 Q36004707-C6BD8210-CBD7-49E7-9719-B7A7D771F2D3 Q36109953-A010E9C8-60A2-4EC7-BECD-444DEAAE7F05 Q36118086-46828A1D-A6BB-400B-AD25-E294AB5B3562 Q36277369-1A9E462B-C562-4803-B385-E2A4F46200B1 Q36685551-A6130AFB-BBB4-46D7-BFCA-5774FC015CF9 Q36845851-75EBA7F1-1869-4175-B8B8-C8C84A1FF1C1 Q37012246-991FEBD2-BC63-46C3-A060-C5D86F12A30B Q37697695-8AFFF934-B083-475D-BC16-84F6E67AD3F8 Q37952284-BDB28E27-566F-4162-B5F9-2D243BDE6A6A Q37982182-E8FF42D3-B5C5-412C-B581-1612CECB8C27 Q38028470-5820C5AC-204A-41E0-9667-A44C008C9A3E Q38101671-58CD64A5-FAC5-4ED4-9AB0-F54A8A8E646A Q38103582-74AA61EE-0D7E-4B1B-86CE-D0DD5C02D258 Q38161536-9ACDC61C-08DA-4A45-8C4E-697A7C88846B Q38170150-4E2EF389-4C9C-4037-998C-0C7D79B2247D Q38492085-4EC1B721-C0DD-4973-AB0E-1900ACD7B929 Q38578686-D92129E0-389F-4871-881B-875E555BB4D9 Q38864758-FF2AF76E-1BD7-43E1-A36D-11C7EB4F41F1 Q40538846-76DF641E-0391-4163-B385-24A3742A5994 Q46291182-611DD8D4-74D7-4F2D-B237-BF63CA0C32B2 Q46610423-7D724A25-17D7-4434-B73E-F63BC9476EF7 Q57299995-8DB01D47-ECAF-4970-9F3E-8062DD4280A1 Q58735079-9EB54EF0-D0BF-412A-B94C-EF787B4EA4F6

P2860

Inhibition of MHC II gene transcription by nitric oxide and antioxidants.

http://www.wikidata.org/entity/Q35699343

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Inhibition of MHC II gene transcription by nitric oxide and antioxidants.

@ast

Inhibition of MHC II gene transcription by nitric oxide and antioxidants.

@en

type

label

Inhibition of MHC II gene transcription by nitric oxide and antioxidants.

@ast

Inhibition of MHC II gene transcription by nitric oxide and antioxidants.

@en

prefLabel

Inhibition of MHC II gene transcription by nitric oxide and antioxidants.

@ast

Inhibition of MHC II gene transcription by nitric oxide and antioxidants.

@en

P1433

Q35699343-0B3F425C-7753-4022-B927-AA2BF089A66B

P1476

Q35699343-B278E4F7-6F0D-44A7-B56A-5096E3B17FA5

P2093

Q35699343-6CA8013A-59FB-42BB-BF17-7E991B778E03

Q35699343-80EF123E-76C1-4238-AF7A-401B97DF111E

P2860

Q35699343-078BE37B-90A3-48DD-BA10-CDB1CAF6FD69

Q35699343-11A0BE98-2F72-4CE4-B46B-5642175AFE13

Q35699343-1AA86689-DAB2-4A97-8D0D-0F2D8C313A1A

Q35699343-1F67492F-5183-4A6A-BE16-45D61CE202CA

Q35699343-20BDA725-FA3A-4F42-B978-88A8D6EFC674

Q35699343-22D2F241-DAD5-4F9B-99D8-5D1DFA5049F7

Q35699343-2390526C-F5B3-4C0A-8BD9-B4677AB22C30

Q35699343-29B754EF-1180-4427-BBF7-0317030FE2E0

Q35699343-2D08391F-9464-4BB3-A3DB-F85F1922DDC2

Q35699343-2DDFE81F-63D5-4B5A-BDDE-495BF107CD48

P304

Q35699343-1864185A-4FBE-4644-B60F-7BDE24A1CE72

P31

Q35699343-50F610B4-0204-4337-9170-8C15220FB168

P356

Q35699343-D8466536-FE6F-4C18-8CA0-3C7B79F6A56F

P433

Q35699343-AA462ACA-48C4-445D-9440-0026469D7743

P478

Q35699343-D25E990E-AE90-481F-A3E1-972E38E5EA48

P577

Q35699343-B9BBE9B7-D1A4-423A-96B7-8C16C82D3DF5

P5875

Q35699343-1D62F50F-CB18-4F05-913A-FFDFD67EE35D

P698

Q35699343-177A12B5-73EE-4193-9923-BF6A409E9176

P932

Q35699343-2D97850E-5582-4FF6-97DD-9A31E3CA167F

P356

1381612043452893

P1433

Current Pharmaceutical Design

P1476

Inhibition of MHC II gene transcription by nitric oxide and antioxidants.

@en

P2093

James K Liao

http://www.w3.org/2001/XMLSchema#string

Olivier Harari

http://www.w3.org/2001/XMLSchema#string

P2860

A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients

Inhibition of Stat1-mediated gene activation by PIAS1

A family of cytokine-inducible inhibitors of signalling

A new protein containing an SH2 domain that inhibits JAK kinases

RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency

Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)

Class II transactivator: mastering the art of major histocompatibility complex expression

A new member of the leucine zipper class of proteins that binds to the HLA DR alpha promoter

The bare lymphocyte syndrome and the regulation of MHC expression

Genetic control of MHC class II expression

P304

893-898

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1381612043452893

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8668091

http://www.w3.org/2001/XMLSchema#string

P698

15032692

http://www.w3.org/2001/XMLSchema#string

P932

2633593

http://www.w3.org/2001/XMLSchema#string